Department of Orthopaedics, First Affiliated Hospital, Third Military Medical University, Chongqing, People's Republic of China.
PLoS One. 2012;7(8):e42569. doi: 10.1371/journal.pone.0042569. Epub 2012 Aug 3.
Small-diameter (<4 mm) vascular constructs are urgently needed for patients requiring replacement of their peripheral vessels. However, successful development of constructs remains a significant challenge. In this study, we successfully developed small-diameter vascular constructs with high patency using our integrally designed computer-controlled bioreactor system. This computer-controlled bioreactor system can confer physiological mechanical stimuli and fluid flow similar to physiological stimuli to the cultured grafts. The medium circulating system optimizes the culture conditions by maintaining fixed concentration of O(2) and CO(2) in the medium flow and constant delivery of nutrients and waste metabolites, as well as eliminates the complicated replacement of culture medium in traditional vascular tissue engineering. Biochemical and mechanical assay of newly developed grafts confirm the feasibility of the bioreactor system for small-diameter vascular engineering. Furthermore, the computer-controlled bioreactor is superior for cultured cell proliferation compared with the traditional non-computer-controlled bioreactor. Specifically, our novel bioreactor system may be a potential alternative for tissue engineering of large-scale small-diameter vascular vessels for clinical use.
我们成功地开发了一种使用整体设计的计算机控制生物反应器系统的小直径(<4 毫米)血管构建体,具有高通畅率。这种计算机控制生物反应器系统可以为培养的移植物提供类似于生理刺激的生理机械刺激和流体流动。通过保持培养基中 O(2)和 CO(2)的固定浓度、恒定供应营养物质和废物代谢物以及消除传统血管组织工程中复杂的培养基更换,培养基循环系统优化了培养条件。新开发的移植物的生化和力学测定证实了生物反应器系统在小直径血管工程中的可行性。此外,与传统的非计算机控制生物反应器相比,计算机控制生物反应器更有利于培养细胞的增殖。具体来说,我们的新型生物反应器系统可能是用于临床应用的大规模小直径血管组织工程的潜在替代方案。